Ticker,Title,Link
RLMD,"Analysts Offer Insights on Healthcare Companies: Relmada Therapeutics (RLMD) and Neumora Therapeutics, Inc. (NMRA)",8/12/2024 8:12:51 AM
RLMD,Optimistic Outlook for Relmada Therapeutics: Strategic Trial Enhancements and Solid Financial Position,8/9/2024 9:58:11 AM
RLMD,RLMD Stock Earnings: Relmada Therapeutics Beats EPS for Q2 2024,8/8/2024 2:55:42 AM
RLMD,Relmada Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update,8/7/2024 10:05:00 PM
RLMD,"Relmada Therapeutics to Report Second Quarter 2024 Financial Results on August 7, 2024",8/5/2024 1:30:00 PM
RLMD,Relmada Therapeutics’ REL-1017: Strong Buy on Robust Trial Design and Market Potential,6/10/2024 10:07:13 AM
RLMD,Keurig Dr Pepper To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday,6/5/2024 2:40:49 PM
RLMD,7 Penny Biotech Stocks to Triple Your Investment,5/28/2024 10:10:00 AM
RLMD,Wall Street Analysts Are Bullish on Top Healthcare Picks,5/24/2024 6:22:43 AM
RLMD,Buy Rating Affirmed for Relmada Therapeutics on Strong Clinical Trials and Financial Footing,5/10/2024 6:07:17 AM
RLMD,Relmada Therapeutics GAAP EPS of -$0.72 beats by $0.15,5/9/2024 4:41:10 PM
RLMD,Optimistic Buy Rating for Relmada Therapeutics Amidst Strong Phase 3 Trial Prospects and Financial Stability,3/21/2024 6:45:41 AM
RLMD,"XTIA, PSNL and LIDR among mid-day movers",3/20/2024 4:25:51 PM
RLMD,Relmada Therapeutics GAAP EPS of -$0.84,3/19/2024 8:22:18 PM
RLMD,Relmada Therapeutics FY 2023 Earnings Preview,3/18/2024 9:35:40 PM
RLMD,Biotech High-Flyers That Just Hit 52-Week Highs ,2/5/2024 10:36:07 AM
RLMD,"Conmed, Relmada Therapeutics among healthcare movers",2/1/2024 3:00:10 PM
RLMD,Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session,1/4/2024 7:37:45 PM
RLMD,Relmada Therapeutics: Advancements in MDD and MASLD Programs Bolster Buy Rating,11/10/2023 11:44:28 AM
RLMD,"Buy Rating for Relmada Therapeutics: Efficient Management, Promising Trials and Prudent Financial Control",11/9/2023 7:11:44 PM
RLMD,"Analysts’ Top Healthcare Picks: Immuneering (IMRX), PepGen Inc. (PEPG)",10/17/2023 5:20:07 AM
RLMD,Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday,10/4/2023 11:37:44 AM
RLMD,"Analysts Offer Insights on Healthcare Companies: AngioDynamics (ANGO), Enlivex (ENLV) and Relmada Therapeutics (RLMD)",9/25/2023 10:20:36 AM
RLMD,"Relmada Therapeutics: Long-term Study With REL-1017 Shows Rapid, Sustained Therapeutic Effects ",9/20/2023 2:44:51 PM
RLMD,Mizuho Securities Reaffirms Their Buy Rating on Relmada Therapeutics (RLMD),8/23/2023 5:05:08 PM
RLMD,"Eton, Semler top healthcare gainers; Cano, Kezar among losers",8/11/2023 2:14:56 PM
RLMD,Relmada Therapeutics (RLMD) Gets a Buy from Mizuho Securities,8/9/2023 5:45:10 PM
RLMD,Relmada Therapeutics GAAP EPS of -$0.84 beats by $0.06,8/8/2023 8:44:44 PM
RLMD,"FDA's Rejection of Sage/Biogen's Zuranolone Boosts Prospects for Axsome's Auvelity, Analyst Says",8/7/2023 6:06:57 PM
RLMD,7 Healthcare Stocks to Ditch Before They Make Your Portfolio Sick,7/31/2023 10:10:05 AM
RLMD,A Golden Ticket to Profiting From ‘Hidden’ Bull Markets,7/9/2023 3:00:41 PM
RLMD,Analysts Offer Insights on Healthcare Companies: Verastem (VSTM) and Relmada Therapeutics (RLMD),6/15/2023 8:20:15 AM
RLMD,"RLMD NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Relmada Therapeutics, Inc. Investors With Losses to Inquire About Securities Class Action Investigation - RLMD",6/14/2023 8:30:00 PM
RLMD,"ROSEN, A LEADING LAW FIRM, Encourages Relmada Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - RLMD",6/3/2023 2:00:00 AM
RLMD,SVB Securities Reaffirms Their Buy Rating on Relmada Therapeutics (RLMD),5/15/2023 10:05:44 AM
RLMD,Mizuho Securities Sticks to Their Buy Rating for Relmada Therapeutics (RLMD),5/12/2023 2:15:06 AM
RLMD,Relmada Therapeutics GAAP EPS of -$0.87 beats by $0.02,5/11/2023 8:17:58 PM
RLMD,SVB Securities Sticks to Their Buy Rating for Relmada Therapeutics (RLMD),3/28/2023 10:05:40 AM
RLMD,Relmada making changes to phase 3 depression candidate trial,3/24/2023 6:28:18 PM
RLMD,Relmada Therapeutics Non-GAAP EPS of -$5.30 misses by $1.28,3/23/2023 8:02:15 PM
RLMD,"SABR, ENVX and RLMD are among after hour movers",3/15/2023 9:27:01 PM
RLMD,SVB Securities Keeps Their Buy Rating on Relmada Therapeutics (RLMD),1/23/2023 12:25:17 PM
RLMD,Mizuho Securities Sticks to Their Buy Rating for Relmada Therapeutics (RLMD),1/17/2023 9:15:12 AM
RLMD,"HUYA, KALA and EIGR among mid-day gainers and losers",12/28/2022 6:00:18 PM
RLMD,"EH, RLMD and DFLI among mid-day movers",12/12/2022 6:03:46 PM
RLMD,"HUYA, MMAT and RLMD among mid-day movers",12/9/2022 6:06:27 PM
RLMD,S&P 500 Rises 0.5%; Ciena Posts Upbeat Q4 Results,12/8/2022 8:41:33 PM
RLMD,Relmada Therapeutics tumbles 37% post market on late-stage depression drug data,12/7/2022 10:30:02 PM
RLMD,Relmada Therapeutics (RLMD) Gets a Buy from Mizuho Securities,11/11/2022 11:55:16 AM
RLMD,Relmada Therapeutics GAAP EPS of -$1.31,11/10/2022 9:22:56 PM
RLMD,Relmada spikes as Steve Cohen’s Point72 discloses 7% stake,10/17/2022 5:33:20 PM
RLMD,Relmada's Trial Failure Removes Competitor Risk For This Company's Newly Launched Depression Product,10/14/2022 5:30:37 PM
RLMD,Dow Surges 950 Points; S&P 500 Rises 3%,10/13/2022 9:13:04 PM
RLMD,Axsome to face payer headwinds as depression therapy rolls out: BofA,10/7/2022 3:42:35 PM
RLMD,"Catalyst watch: Tesla AI Day, Amazon product event, JetBlue trial and Nike earnings",9/23/2022 7:00:15 PM
RLMD,Relmada Therapeutics (RLMD) Gets a Buy from Mizuho Securities,9/20/2022 2:05:16 PM
RLMD,The Bull Market Is Still Alive,8/29/2022 7:30:51 PM
RLMD,Relmada Therapeutics GAAP EPS of -$1.33,8/11/2022 8:20:23 PM
RLMD,Recap of Tuesday's Biotech Catalysts - End Of the Day Summary,8/10/2022 12:29:58 AM
RLMD,Relmada Secures FDA Fast Track Status For Depressive Disorder Candidate,8/9/2022 5:12:17 PM
RLMD,10 Biggest Price Target Changes For Monday,5/9/2022 2:47:46 PM
RLMD,Relmada Therapeutics GAAP EPS of -$1.40 misses by $0.13,5/5/2022 9:15:09 PM
RLMD,Relmada Therapeutics files for mixed shelf offering,4/7/2022 10:18:31 PM
RLMD,"The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy",4/6/2022 2:02:15 PM
RLMD,Here's Why Relmada Therapeutics Shares Are Rising,3/24/2022 6:45:14 PM
RLMD,Relmada Therapeutics GAAP EPS of -$1.80 beats by $0.04,3/23/2022 8:25:39 PM
RLMD,Relmada Aces REL-1017 Vs Ketamine Study For Abuse Potential,2/23/2022 5:42:48 PM
RLMD,"Alnylam, Crispr Therapeutics among Goldman's biopharma M&A targets for 2022",12/19/2021 2:00:00 PM
RLMD,"The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO",12/9/2021 1:47:39 PM
RLMD,"BGFV, DWAC and EOLS among after-hours movers",12/8/2021 10:49:00 PM
RLMD,"Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2021",11/18/2021 4:19:52 PM
RLMD,Relmada Therapeutics EPS misses by $0.84,11/11/2021 9:46:43 PM
RLMD,FDA Confirms Relmada Not Required To Conduct Two-Year Carcinogenicity Study To Support REL-1017 Data ,10/4/2021 2:57:25 PM
RLMD,"The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma",8/12/2021 2:09:26 PM
RLMD,"The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering",8/11/2021 2:14:38 PM
RLMD,Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2021 Financial Results,8/10/2021 10:05:00 PM
RLMD,"The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight",8/8/2021 4:11:24 PM
RLMD,"Relmada Therapeutics to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 10, 2021",8/5/2021 10:15:00 PM
RLMD,"Relmada Sees Price Target Bump From Leerink, Truist After Positive Data From MDD Candidate",7/27/2021 6:42:25 PM
RLMD,"The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs",7/23/2021 1:45:07 PM
RLMD,Relmada Therapeutics In-Licenses Psilocybin Program From Arbormentis,7/20/2021 6:37:14 PM
RLMD,Relmada Therapeutics to Present Data at the College on Problems of Drug Dependence 83rd Annual Scientific Meeting,6/15/2021 2:00:00 PM
RLMD,Relmada Therapeutics EPS misses by $0.25,3/23/2021 8:31:48 PM
RLMD,Will 2021 Continue To Be An Exciting Year For Relmada Therapeutics? ,1/13/2021 9:16:20 AM
RLMD,Enrollment underway in Relmada Therapeutics' late-stage depression study with REL-1017,12/7/2020 5:42:37 PM
RLMD,"Miragen Therapeutics, Titan Pharmaceuticals leads healthcare gainers; Neovasc, Akerna among major losers",10/28/2020 3:01:35 PM
RLMD,Relmada Therapeutics beefs up leadership team; updates on REL-1017 program,10/27/2020 1:24:34 PM
RLMD,Relmada Therapeutics (RLMD): Sending The Right Signals? ,4/28/2020 12:46:01 PM
RLMD,Ocugen Stock Is Not for the Faint of Heart,1/15/2020 6:25:47 PM
RLMD,"Top Gainers: CLSD Making A Second Try, RLMD Abuzz, Busy Year Ahead For BTAI ",12/17/2019 7:59:20 AM
RLMD,"APTO On The Move, PLX To Effect Reverse Split, SCYX Plunges ",12/10/2019 7:51:30 AM
RLMD,"AUPH Soars On Lupus Trial Results, ACAD On Watch, ALNA Trims Workforce ",12/5/2019 5:39:28 AM
RLMD,"5 Top Gainers In Healthcare Sector (RETA, ABEO, CNST...) ",10/16/2019 3:46:06 AM
RLMD,"RETA Surges On Trial Data, RVNC On Track, All Eyes On RLMD Today ",10/15/2019 7:41:02 AM
